BioSmart Co., Ltd. Overview
BioSmart began as a domestic payment-card manufacturer. Over roughly 20 years under its controlling shareholder, Chairman Park Hye-rin, it has turned into a diversified, acquisition-built mini-conglomerate. The founding business makes and personalizes credit, check, IC, metal and access cards for Korean card issuers. Since 2022, however, consolidated revenue has been dominated by copper winding wire made by its 47.6%-owned, separately listed subsidiary TC Materials. That business supplies continuously transposed conductor (CTC), flat (rectangular) copper wire and enamelled wire to transformer, cable and EV-component makers. Smaller segments cover generic pharmaceuticals (Austin Pharm), liquor-trade payment and ERP systems (Bona), and publishing. BioSmart also holds stakes in listed affiliates Omni System and The Lami and in an English-education business (Wall Street Institute Korea). The investment case rests on the power-grid copper cycle running through TC Materials. The discount rests on thin margins, opaque group governance and an absence of shareholder returns. In October 2026 the stock traded at about 0.45x book value.
Company's own description (paraphrased from DART business-report summaries)
The DART-derived summary published by DataHero/ValueLine describes BioSmart as follows. Smart-card manufacturing is its core activity, alongside pharmaceuticals, liquor-payment services, book publishing, and heavy-electrical/copper products.
-
The smart-card business claims domestic market leadership. It makes credit cards, metal cards, IC cards and access cards.
-
The pharmaceutical business carries about 300 products. The split is roughly 60% prescription (ETC) and 40% over-the-counter (OTC).
-
The liquor-payment business provides the liquor purchase-only card, liquor-distribution ERP and the National Tax Service (NTS) liquor-distribution information system. It describes itself as a leader in that niche.
-
Publishing covers trade books, a "Sigong" magazine and a book club.
-
The heavy-electrical/copper business makes flat copper wire for transformers and rotating machines and manufactures and repairs motor stators.
Management frames the diversification as a hedge against the maturity of its original business, seeking synergy by combining unrelated industries.
A separate data provider (RiskWeather) also lists diagnostic kits, continuously transposed windings and turbine-generator work among the activities.
Independent characterization
In substance, BioSmart is now a holding-style operating company. Its consolidated P&L is driven by an industrial copper-processing subsidiary, not by cards.
On the 2Q 2026 revenue basis shown by Butler, the mix was:
An earlier Butler snapshot for the same period showed 72/17/8/2/1. The economics therefore follow copper prices, the cost of passing copper through to customers, and the Korean and US transformer and cable capex cycle more than card-issuance volumes.
The standalone parent (the card business plus head office) generated KRW 103.3B of revenue in FY2025 with 168 employees (DART via ETF Shopping). That is only about 21% of consolidated revenue of KRW 482.8B.
Business and revenue model
| Dimension | Characterization |
|---|---|
| Revenue type | Predominantly product sales (copper wire, cards, drugs). There are service and transaction elements in card personalization and issuing services, liquor-payment/ERP services and publishing. No material subscription or licensing revenue is disclosed. |
| Value-chain position | Copper: mid-stream processor. It converts purchased copper rod/cathode into engineered conductors for OEMs (HD Hyundai Electric, Hyosung Heavy Industries, Iljin Electric, LS Cable, Taihan Cable, Samsung Electronics, Hyundai Motor). Cards: contract manufacturer and personalizer for card issuers, using third-party chip operating systems (a 2010s trade report grouped BioSmart with makers that rely on foreign COS, as opposed to vertically integrated COS developers such as KONA I and UbiVelox). Pharma: generic ETC/OTC manufacturer and marketer. |
| Customer types | B2B: card issuers and banks; transformer, cable and EV-component makers; pharmacies and hospitals via distributors and CSOs; liquor wholesalers and retailers; book consumers (B2C). |
| End-markets | Payments/financial services; power transmission and distribution; electric vehicles; home appliances; healthcare; the liquor trade; publishing; education (affiliate). |
| Pricing mechanics (copper) | Prices are copper-linked with a pass-through. Timing mismatches compress margins when copper rises: TC Materials' 2Q26 operating margin fell to 3.1% from 6.3% in 1Q26 because customers reflected copper prices at different times (DS Investment, Sept 2026). |
Strategy
Stated strategy
The DART business report (as summarized) frames the strategy as cross-industry combination. Its stated aim is to hedge the risks of operating in mature industries and to create synergies across unrelated businesses.
In practice, the strategy has been serial acquisition of distressed or undervalued companies, followed by operational normalization. Examples:
-
KBC (2004, after the card crisis).
-
Omni System (2009, after the financial crisis).
-
Austin Pharm (2016, after a trust crisis).
-
TC Materials (2021–23, through rehabilitation).
-
The Lami (2023, during a trading suspension).
-
WSI Korea (2024).
Dealsite (April 2026) reports that Park prefers to demonstrate value through earnings rather than short-term share-price support. The Lami's management said it was not considering shareholder returns for now.
Initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| TC Materials KOSDAQ listing (SPAC) | 15 May 2025 | Crystallized a listed value for the copper subsidiary. IPO guidance was KRW 359.2B revenue and KRW 17.9B operating profit. | FY2025 actual: KRW 299.1B / KRW 6.8B, an operating-profit miss of about 60% (Dealsite) |
| TC Materials capacity expansion | Announced Dec 2025 | Flat wire + CTC capacity rising from 12,400 t to 21,200 t; enamel wire to 17,400 t; EHV materials to 7,000 t | CTC lines to 13 by Oct 2026 (DS Investment) |
| Superconducting wire national R&D project | Feb 2026 | Reported near completion | Commercialization not disclosed |
| WSI Korea control | 2024–2026 | Stake bought (45.9% for about KRW 1.3B), diluted to the 30% range, then lifted via loan-to-equity conversion (43.61%) | Rationale undisclosed; company declined comment (Dealsite) |
| Treasury share elimination | 1H 2026 | KRW 3.0B treasury stock removed; issued shares from about 26.16M to 25.27M | Completed per balance-sheet data |
| Group "value-up" pressure | 2,026 | Affiliates face tighter delisting rules for low-priced stocks; Omni System cancelled treasury shares (Apr 2026) and approved a 5:1 reverse split (Oct 2026) | In progress |
| Eco-friendly cards / de-plastic positioning | Ongoing | Patents for paper diagnostic-kit panels and eco card materials | Product-level revenue not disclosed |
Guidance and medium-term targets
| Entity | Target / forecast | Source | Status |
|---|---|---|---|
| TC Materials | FY2025 guidance KRW 359.2B revenue / KRW 17.9B operating profit (given at listing) | Dealsite | Missed |
| TC Materials | Third-party forecast: operating profit KRW 21.3B (2026), KRW 36.7B (2027) | DS Investment, Sep 2026 | Not company guidance |
| Austin Pharm | KRW 100B revenue by 2024, incl. KRW 20B+ OTC (stated 2021–22) | Daily Pharm | Achievement not disclosed; pharma's roughly 7% share of group revenue suggests it was not met (analyst inference) |
BioSmart provides no public guidance and no medium-term financial targets. Subsidiary-level targets:
ESG and sustainability commitments: not publicly disclosed.
Products & Services
Cards (BioSmart parent)
| Product / service | Description and capabilities | Target customer | Notes |
|---|---|---|---|
| Magnetic-stripe (MS) cards | Credit-card-size plastic cards with magnetic stripe | Card issuers, retailers, membership programs | Legacy product (S&P / Morningstar) |
| Contact IC cards | Embedded microprocessor/memory chip; EMV-capable | Banks, card issuers | Uses third-party chip OS |
| Contactless and combi (dual-interface) cards | RF interface for tap payments and transit | Issuers, transit | Global contactless share of payment-card shipments reached 92% in 2024 (Smart Payment Association, via GII) |
| Metal cards | Premium metal-bodied payment cards | Premium card programs | Listed by DART as a key product |
| Eco-material cards (incl. hanji paper card) | Cards in non-plastic or eco materials. BioSmart reports converting several issuers' plastic cards to eco materials. | ESG-sensitive issuers | Cited when the stock rallied on de-plastic policy news (Asia Economy, Apr 2025) |
| RFID, 3D lenticular and bio cards | Specialty cards | Corporate, ID, promotional | Morningstar description |
| ID / access cards | Employee and access credentials | Corporates, institutions | DART summary |
| Card-issuing equipment | Transit and smart-card issuing machinery; credit-card issuing machinery (encoding, embossing, indent) | Issuers, bureaus | S&P / CB Insights |
| Personalization services | MS encoding, IC-chip personalization, photo transfer | Issuers | S&P |
| Issuing software | Software for credit-card issuing | Issuers, bureaus | S&P |
Pricing models are not publicly disclosed.
Heavy-electrical / copper products (TC Materials)
| Product | Description | End-use / customers | Capacity / notes |
|---|---|---|---|
| CTC (continuously transposed conductor) | Multi-strand transposed copper conductor for transformer windings, from medium voltage to extra-high voltage; oxygen-free grades for EHV | HD Hyundai Electric, Hyosung Heavy Industries, Iljin Electric | Lines going from 5 to 13 by Oct 2026; output to about 1,600 t/month, more than 3x prior (DS Investment, Sep 2026). Planned 2026 capacity 13,200 t (Asia Economy, Dec 2025). |
| Flat (rectangular) copper wire | Rectangular wire for transformers and rotating machines; Korea-first subsea-cable grade (May 2025) | Transformer and cable makers | Planned 2026 capacity 8,000 t (flat wire + CTC combined: 12,400 t in 2025 rising to 21,200 t in 2026) |
| Enamelled copper wire | Insulated magnet wire. Korea-first development for subsea-cable and EHV power-cable materials. | Cable makers (LS Cable, Taihan), appliances, EV components | Capacity 15,000 t rising to 17,400 t |
| EHV cable materials | Copper materials for extra-high-voltage cable | LS Cable, Taihan Cable | Capacity 6,000 t rising to 7,000 t |
| Motor stators / repair | Stator manufacture and repair; turbine-generator and rotating-machine work | Utilities, industrials | DART summary; RiskWeather |
| Superconducting wire (development) | Government (national R&D) project reported near completion in Feb 2026 | Future grid applications | Finance Scope headline (Feb 2026) |
At listing (May 2025), power-sector products were 96.9% of TC Materials' sales, and power infrastructure was more than 60% of product sales (Finance Scope).
Pharmaceuticals (Austin Pharm)
| Line | Description | Notes |
|---|---|---|
| ETC (prescription) generics | About 60% of the roughly 300-product portfolio | UBIST prescription value rose from KRW 7.3B (2016) to KRW 48.3B (2021) (Daily Pharm) |
| OTC | About 40% of the portfolio | Samsung Pharm co-promotion of 11 OTC products (Dec 2021); FY2024 OTC target of KRW 20B+ (2022 statement) |
| Manufacturing | Ansan, Gyeonggi-do plant | Daily Pharm (Jun 2022) |
Named flagship brands are not disclosed in retrieved sources.
Liquor payment (Bona)
| Offering | Description |
|---|---|
| Liquor purchase-only card (주류구매전용카드) | Debit-style card mandated since 2001 for wholesaler–retailer liquor transactions; transaction data are reported to the NTS |
| NTS-linked credit-card settlement | Launched with KCP (Korea Cyber Payment) in June 2014, through "Bona Bank", to allow deferred payment |
| Liquor-distribution ERP | ERP for liquor wholesalers |
| NTS liquor-distribution information system | System services linked to the NTS traceability regime |
| GetJu (겟주) smart-order app | Consumer liquor smart-order service. TheVC lists a press headline indicating the service ended. |
Bona Networks: founded August 2000; CEO Yoon Ho-kwon; 49 employees (Feb 2026); 6 patents (TheVC).
Publishing
Trade books, the Sigong magazine and a book club (DART summary). Titles, revenue and pricing are not publicly disclosed in retrieved sources.
Financial Narrative
Source: S&P Global Market Intelligence via StockAnalysis.com (annual, FY2021–FY2025; KRW millions). DART-based aggregator figures are shown where they differ.
Income statement
DART-basis operating income and net income are from ETF Shopping / Butler (KRW 100M units converted to KRW M). The FY2022–23 operating-income gaps reflect classification differences between S&P and DART.
Dividends per share. No dividend was declared for FY2022–FY2025. Cash dividends of KRW 360M were paid in FY2022 (payout ratio 49.9% on FY2022 earnings, S&P).
Revenue CAGR (analyst calculation): FY2021–FY2025 is 26.4% a year, almost entirely acquisition-driven. FY2022–FY2025, the organic-ex-TC-consolidation proxy, is 7.2% a year.
Quarterly trajectory (DART, via ETF Shopping)
The trailing twelve months to June 2026 (S&P) show:
1H26 revenue of KRW 312.9B was up 34.2% on 1H25 (KRW 233.1B); 1H26 operating income of KRW 15.2B was up 55% (analyst calculation from quarterly data).
Balance sheet
At March 2026, total debt was KRW 77.7B (short-term KRW 47.0B, long-term KRW 27.0B, leases KRW 3.7B), cash and short-term investments KRW 25.7B, and net debt KRW 51.9B (S&P).
Ratios
Interest coverage and DIO are analyst calculations from S&P data. A full cash conversion cycle cannot be computed: from FY2024, S&P reclassifies trade receivables into "other current assets", which breaks the receivables series. Receivable days are therefore not publicly disclosed on a consistent basis.
Commentary on trends and drivers
Scale versus quality. Consolidating TC Materials (from FY2022) changed the group's profile. Revenue roughly doubled, but gross margin fell from 36% to the high teens because copper processing is a low-margin, pass-through business. The fall reflects mix: the high-margin card business was diluted by copper volumes. Underlying deterioration is not the main driver.
Operating inflection in FY2024–FY2025. Operating income roughly doubled in FY2024 (S&P: KRW 9.8B to KRW 19.5B; DART: KRW 10.1B to KRW 20.2B). It rose again in FY2025 to KRW 22.7B on flat revenue, with SG&A held at about KRW 59B against KRW 62.5B in FY2023. 1H26 shows strong top-line acceleration (+34%), led by TC Materials (+55%). The 2Q26 margin dip came from timing in copper price pass-through.
Earnings quality is noisy. Below the operating line, results swing on equity-method income, impairments and one-off gains:
-
FY2023 net income of KRW 17.9B included a KRW 15.9B gain on sale of investments.
-
FY2024 attributable net income was nearly zero (KRW 0.1B) despite KRW 19.5B of operating income. The causes were KRW 5.0B of other unusual items, KRW 1.9B of asset write-downs, KRW 4.6B of other non-operating losses and an 85% effective tax rate.
-
Reported ROE has therefore ranged from -1.2% to 14.7% with no clear relationship to operations.
Cash conversion is weak and investment has stepped up. Operating cash flow was KRW 1–6B a year in FY2021–FY2024, far below EBITDA, as working capital absorbed KRW 9–15B a year. FY2025 OCF improved sharply to KRW 24.1B. Capex jumped to KRW 33.2B, however, and land on the balance sheet rose from KRW 23.6B to KRW 44.4B. The result was negative free cash flow (-KRW 9.2B FY2025; -KRW 22.3B TTM to Mar-26).
Deleveraging, then re-leveraging. Net debt / EBITDA fell from 4.3x (FY2021) to 1.2x (FY2025). Drivers were higher EBITDA, KRW 24.6B of divestiture proceeds in FY2023, and the TC Materials SPAC listing, which raised NCI equity from KRW 27.0B to KRW 43.7B. Net debt then climbed back to KRW 51.9B by March 2026 as capex and working capital absorbed cash. Short-term debt dominates the borrowing structure, which creates refinancing exposure.
Minority leakage. Non-controlling interests rose from -KRW 7.5B (FY2021) to KRW 46.2B (Mar-26). This reflects TC Materials' public float and other partly owned subsidiaries. Minority interests absorbed KRW 4.8B of TTM earnings to Jun-26, so a growing share of consolidated profit is not attributable to BioSmart shareholders.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Share of revenue % (2Q26, Butler snapshot A) | Share of revenue % (2Q26, Butler snapshot B) |
|---|---|---|
Heavy-electrical / copper products | 74 | 72 |
Cards | 16 | 17 |
Pharmaceuticals | 7 | 8 |
Liquor payment | 3 | 2 |
Publishing | 1 | 1 |
Heavy-electrical / copper | TC Materials Co., Ltd. (KOSDAQ 125020; 47.61% owned at end-2025) | CTC for transformers; flat (rectangular) copper wire incl. a subsea-cable grade; enamelled copper wire; extra-high-voltage cable materials; motor stator manufacture and repair |
Cards | BioSmart Co., Ltd. (parent) | Magnetic-stripe, contact, contactless and dual-interface (combi) IC cards; metal cards; RFID and 3D lenticular cards; ID/access cards; card-issuing equipment and software; MS/IC personalization and photo transfer |
Pharmaceuticals | Austin Pharm Co., Ltd. (80.6% at end-2025) | About 300 generic ETC/OTC products (ETC 60% / OTC 40%) |
Liquor payment | Bona entities (Bona Networks, formerly Bona Bank; Bona Camp 86.18% owned) | Liquor purchase-only card; liquor-distribution ERP; NTS liquor-distribution information-system services; NTS-linked credit-card settlement |
Publishing | Group publishing affiliate. Daily Pharm (2022) names Sigongsa as the group's "cultural content" company. | Trade books, Sigong magazine, book club |
Investee Details
| Investee | Stake % | Latest total assets (KRW Bn) | Latest net income (KRW Bn) | Notes |
|---|---|---|---|---|
Omni System (KOSDAQ 057540) | 23.36 | 132.5 | 6.72 | Digital meters/AMI; acquired 2009 |
Bona Camp | 86.18 | 23.0 | -1.93 | — |
The Lami (KOSDAQ 032860) | 28.29 | 61.8 | 2.48 | Formerly Human N; acquired 2023 |
TC Materials (KOSDAQ 125020) | 47.61 | 76.2 | 6.27 | Copper winding wire |
Austin Pharm | 80.60 | 41.3 | 0.20 | Generic pharma |
Wall Street Institute Korea | 43.61 | — | — | English education |
Horizon IM | 9.90 | — | — | Not described |
T-money (Korea Smart Card) | 0.37 | 729.1 | 28.5 | Transport card operator (financial investment) |
Solidus Smart Bio Investment Fund | 0.50 | — | — | VC fund |
IBKC-Gaia MSP New Technology Fund No.1 | 5.00 | — | — | VC fund |
2014 Solidus Growth Ladder Startup Fund | 2.09 | — | — | VC fund |
SGI Unicorn Startup Fund | 1.70 | — | — | VC fund |
“—” = not publicly disclosed.
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Mn) | 189,183 | 391,822 | 456,164 | 484,310 | 482,776 |
Revenue growth (%) | 13.67 | 107.11 | 16.42 | 6.17 | -0.32 |
Gross profit (KRW Mn) | 68,436 | 76,729 | 79,006 | 82,262 | 85,256 |
SG&A (KRW Mn) | 56,114 | 61,167 | 62,452 | 58,515 | 59,480 |
R&D expense (KRW Mn) | 426.86 | 1,168 | 1,341 | 680.12 | 692.89 |
Operating income, S&P basis (KRW Mn) | 7,960 | 9,302 | 9,758 | 19,460 | 22,663 |
Operating income, DART basis (KRW Mn) | 8,000 | 10,200 | 10,100 | 20,200 | 22,600 |
EBITDA (KRW Mn) | 13,591 | 18,874 | 18,247 | 27,664 | 30,098 |
Interest expense (KRW Mn) | 2,041 | 4,396 | 5,962 | 4,638 | 2,857 |
Pre-tax income (KRW Mn) | 1,341 | 1,956 | 21,178 | 7,061 | 14,724 |
Income tax (KRW Mn) | 707.1 | 3,137 | 4,998 | 6,005 | 5,738 |
Net income incl. NCI, DART basis (KRW Mn) | 600 | -1,200 | 16,200 | 1,100 | 9,000 |
Net income attributable to owners (KRW Mn) | 1,392 | 721.31 | 17,907 | 127.17 | 9,009 |
EPS basic (KRW) | 72.53 | 37.57 | 915.15 | 5.61 | 356.45 |
EPS diluted (KRW) | 72.53 | 37.57 | 556.83 | 5.61 | 356.00 |
Effective tax rate (%) | 52.73 | 160.43 | 23.60 | 85.05 | 38.97 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 36.18 | 19.58 | 17.32 | 16.98 | 17.66 |
Operating margin (%) | 4.21 | 2.37 | 2.14 | 4.02 | 4.69 |
EBITDA margin (%) | 7.18 | 4.82 | 4.00 | 5.71 | 6.23 |
Net margin, attributable (%) | 0.74 | 0.18 | 3.93 | 0.03 | 1.87 |
Financial Analysis
| Metric | 1Q24 | 2Q24 | 3Q24 | 4Q24 | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 118.7 | 130.1 | 119.1 | 116.5 | 112.3 | 120.8 | 125.5 | 124.2 | 145.3 | 167.6 |
Operating income (KRW Bn) | 4.3 | 5.0 | 3.8 | 7.2 | 5.6 | 4.2 | 7.6 | 5.1 | 10.1 | 5.1 |
Net income incl. NCI (KRW Bn) | 4.9 | -4.7 | -1.5 | 2.4 | 2.8 | -2.8 | 4.9 | 4.0 | 7.2 | 2.2 |
TTM Metric Details
| TTM metric (to Jun-26) | Value |
|---|---|
Revenue | KRW 562.7B (+20.1%) |
Operating income | KRW 28.1B (margin 5.0%) |
EBITDA | KRW 34.8B |
Net income attributable | KRW 13.5B |
EPS | KRW 533.65 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (KRW Mn) | 225,851 | 237,183 | 260,063 | 262,843 | 309,881 |
Cash and equivalents (KRW Mn) | 13,585 | 19,612 | 20,851 | 10,812 | 30,022 |
Cash and short-term investments (KRW Mn) | 15,274 | 20,282 | 31,343 | 20,842 | 39,111 |
Inventory (KRW Mn) | 50,774 | 57,051 | 53,022 | 50,448 | 52,356 |
Property, plant and equipment (KRW Mn) | 52,866 | 50,080 | 45,029 | 48,818 | 76,845 |
Long-term investments (KRW Mn) | 33,910 | 34,194 | 52,275 | 55,375 | 56,675 |
Goodwill and intangibles (KRW Mn) | 6,219 | 7,181 | 7,192 | 7,474 | 7,648 |
Short-term debt incl. current LTD and leases (KRW Mn) | 40,546 | 72,329 | 72,617 | 39,586 | 46,031 |
Long-term debt incl. leases (KRW Mn) | 33,068 | 11,252 | 16,101 | 24,811 | 29,888 |
Total debt (KRW Mn) | 73,614 | 83,581 | 88,718 | 64,397 | 75,919 |
Net debt (KRW Mn) | 58,340 | 63,298 | 57,375 | 43,555 | 36,808 |
Total liabilities (KRW Mn) | 131,220 | 141,878 | 135,431 | 104,394 | 122,224 |
Equity attributable to owners (KRW Mn) | 99,098 | 96,725 | 111,691 | 129,484 | 143,993 |
Non-controlling interests (KRW Mn) | -7,467 | -4,420 | 9,941 | 26,964 | 43,664 |
Total equity (KRW Mn) | 94,631 | 95,305 | 124,632 | 158,449 | 187,657 |
Working capital (KRW Mn) | 30,498 | 1,466 | 17,982 | 56,479 | 63,994 |
Book value per share (KRW) | 5,161.94 | 5,038.31 | 5,473.19 | 5,123.11 | 5,697.14 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (KRW Mn) | 1,203 | 6,289 | 1,166 | 3,708 | 24,073 |
Capital expenditure, outflow (KRW Mn) | 5,332 | 4,359 | 3,113 | 6,922 | 33,245 |
Free cash flow (KRW Mn) | -4,129 | 1,930 | -1,947 | -3,213 | -9,172 |
Cash acquisitions, outflow (KRW Mn) | 26,748 | 0 | 0 | 0 | 0 |
Divestiture proceeds (KRW Mn) | 0 | 4,000 | 24,646 | 0 | 0 |
Dividends paid (KRW Mn) | 0 | 360 | 0 | 0 | 0 |
Share repurchases (KRW Mn) | 0 | 0 | 0 | 0 | 9.3 |
Equity issued (KRW Mn) | 5,850 | 0 | 0 | 7,996 | 0 |
Net debt issued / repaid (KRW Mn) | 18,746 | 6,553 | 6,060 | -19,157 | 21,233 |
Change in working capital (KRW Mn) | -12,907 | -8,574 | -15,403 | -12,859 | -969.51 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 0.68 | -1.24 | 14.71 | 0.75 | 5.19 |
ROA (%) | 2.53 | 2.51 | 2.45 | 4.65 | 4.95 |
ROIC (%) | 2.83 | -3.61 | 4.38 | 1.52 | 6.49 |
ROCE (%) | 5.80 | 8.50 | 6.80 | 10.50 | 10.30 |
Current ratio (x) | 1.35 | 1.01 | 1.15 | 1.73 | 1.71 |
Quick ratio (x) | 0.64 | 0.48 | 0.61 | 0.27 | 0.44 |
Debt / equity (x) | 0.78 | 0.88 | 0.71 | 0.41 | 0.41 |
Net debt / EBITDA (x) | 4.29 | 3.35 | 3.14 | 1.57 | 1.22 |
Interest coverage, EBIT / interest (x) | 3.90 | 2.12 | 1.64 | 4.20 | 7.93 |
Asset turnover (x) | 0.96 | 1.69 | 1.84 | 1.85 | 1.69 |
Inventory turnover (x) | 2.74 | 5.85 | 6.85 | 7.77 | 7.73 |
Days inventory outstanding (days) | 133 | 62 | 53 | 47 | 47 |
Operating Areas
| Area | Recent trend | Source |
|---|---|---|
Power infrastructure (TC Materials) | Fastest growing: +73.5% YoY in 1Q26 on CTC, flat wire and EHV cable materials | Hankyung / Newsis (May 2026) |
EV components (TC Materials) | +60.1% YoY in 1Q26, helped by customer diversification | Hankyung / Newsis (May 2026) |
Home appliances and other (TC Materials) | Declining: -17.4% YoY in 1Q26 on weak global appliance demand | Hankyung / Newsis (May 2026) |
Cards, pharma, liquor payment, publishing | Share of revenue falling as copper grows; absolute trends not disclosed | Butler |
Capital Markets Data (KRW) and Market Valuation
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end close (KRW) | 5,710 | 3,330 | 3,425 | 3,080 | 3,900 |
Year-end market cap (KRW Mn) | 109,620 | 63,929 | 69,894 | 77,846 | 98,571 |
Year-end enterprise value (KRW Mn) | 118,178 | 123,843 | 156,095 | 156,743 | 160,681 |
Change by Period
| Period | Change (%) | Basis |
|---|---|---|
Year-to-date 2026 (from 3,900 to 2,685) | -31.2 | Analyst calculation |
6 months | -38.6 | ValueLine, 15 Oct 2026 |
52 weeks to 10 Aug 2026 | -10.8 | S&P |
Since FY2023 close (3,425) | -21.6 | Analyst calculation, about 3 years |
Since FY2021 close (5,710) | -53.0 | Analyst calculation, about 5 years |
Other trading data | Value | — |
52-week range | KRW 2,305 – 6,930 (StockHub, Oct 2026) | — |
Beta (5-year) | 0.73 | — |
50-day / 200-day moving average | KRW 2,697.6 / KRW 3,596.7 (S&P, 10 Aug 2026) | — |
Float | 18.58M shares | — |
Average volume (20-day) | About 119,000 shares | — |
Valuation Multiples (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
P/E (x) | 78.72 | 88.63 | 3.90 | 612.13 | 10.94 |
P/B (x) | 1.16 | 0.67 | 0.56 | 0.49 | 0.53 |
EV/EBITDA (x) | 8.70 | 6.56 | 8.55 | 5.67 | 5.34 |
EV/Sales (x) | 0.63 | 0.32 | 0.34 | 0.32 | 0.33 |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
P/E | About 5.0x | TTM attributable net income KRW 13.5B (Butler: 5.03x; ValueLine: 5.05x) |
P/B | About 0.45x | Common equity KRW 148.7B, Mar-26 |
EV/EBITDA | About 4.8x | EV about KRW 166B / TTM EBITDA KRW 34.8B (ValueLine shows 3.70x on its own definition) |
EV/Sales | About 0.30x | TTM revenue KRW 562.7B |
Holding Details
| Holding | Market cap used (KRW Bn) | Stake % | Value to BioSmart (KRW Bn) |
|---|---|---|---|
TC Materials | 171.5 (22 Jul 2026) | 47.61 | About 81.7 |
Omni System | 54.6 (21 Jul 2026) | 23.36 | About 12.8 |
The Lami | 24.0 (31 Jul 2026) | 28.29 | About 6.8 |
Total listed stakes | — | — | About 101 |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | None. Zero sell-side reports (StockHub); no consensus estimates (Investing.com, Stockopedia). |
Dividend history and policy | KRW 360M paid in FY2022 (payout 49.9%); no dividends FY2023–FY2025; no published dividend policy. Stockopedia confirms no current dividend. |
Buybacks | KRW 9.3M repurchased in FY2025; treasury stock (KRW 3.0B) eliminated in 1H26. No buyback authorization disclosed. |
Share count history | Basic weighted shares: 19M (FY2021–22), 20M (FY2023), 23M (FY2024), 25M (FY2025). Dilution came from equity issuance and conversions. Last stock split: 1-for-6 reverse, 20 Sep 2010. |
Credit ratings (Moody's / S&P / Fitch) | None; not rated by international agencies. Domestic ratings not publicly disclosed. |
Debt maturity profile (Mar-26) | Short-term borrowings KRW 47.0B (due within 12 months); long-term debt KRW 27.0B; leases KRW 3.7B. A detailed maturity ladder is not publicly disclosed in retrieved sources. |
Credit-health scores | Altman Z-Score 2.86 (below the 3.0 safe threshold); Piotroski F-Score 4 (S&P) |
Analyst Conclusions
Management guidance and consensus
BioSmart issues no guidance and has no consensus. The only forward-looking third-party figures are DS Investment's operating-profit forecasts for subsidiary TC Materials: KRW 21.3B in 2026 and KRW 36.7B in 2027. The 2026 figure is triple TC's FY2025 standalone operating profit of KRW 6.8B. The 2027 figure assumes full ramp of 13 CTC lines and better product mix.
1H26 group revenue of KRW 312.9B (+34%) puts FY2026 on a path to roughly KRW 600B+ if 2H26 holds at 1H26 levels. This is an analyst extrapolation, not guidance.
Bull case
-
Grid-cycle operating leverage. TC Materials is tripling CTC output into a transformer upcycle. If DS Investment's KRW 36.7B 2027 operating-profit forecast for TC is approached, consolidated operating income could rise well above FY2025's KRW 22.7B. The 1Q26 group operating margin was already 7.0%.
-
Discount to listed holdings. BioSmart's listed stakes are worth about KRW 101B at mid-2026 prices, versus a KRW 67.9B market cap. The operating card business and land holdings (KRW 44.4B) also sit beneath that. Any value-up action — dividends, further cancellation, IR — could narrow the gap. The 1H26 treasury-stock elimination is a first step.
-
Balance-sheet repair already done. Net debt / EBITDA fell from 4.3x to 1.2x (FY2021–FY2025). TTM ROCE is 11.9%. At about 5x P/E and 0.45x P/B, a modest rerating to 0.7x book (the five-year average P/B is 0.74x, per ValueLine) would imply more than 50% upside.
Bear case
-
Earnings do not reach shareholders. Attributable net income was KRW 0.1B in FY2024 despite KRW 19.5B of operating income. Minorities absorbed KRW 4.8B of TTM profit, and FCF was -KRW 22.3B TTM. Growth is consuming cash rather than producing it.
-
Credibility and governance. TC Materials missed its first-year IPO operating-profit guidance by about 60%. Group affiliates face delisting-threshold pressure. Capital allocation includes opaque moves such as the WSI Korea loan-to-equity conversion, with the rationale undisclosed. There is no IR program. The discount may be structural rather than temporary.
-
Copper and concentration risk. Margins are hostage to copper pass-through timing (2Q26 TC margin 3.1%) and to a few customers (top-3 about 50%). A slowdown in transformer orders or adverse copper moves would hit volume and margin together.
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters |
|---|---|
| 3Q26 report (due by mid-November 2026) | Whether TC Materials' margin recovers from 3.1% as copper pass-through renegotiation (current-month copper pricing) takes effect |
| Completion and ramp of the 13-line CTC capacity (Oct 2026) | Monthly output about 1,600 t |
| FY2026 business report (about March 2027) | Segment profit disclosure; FCF; capex purpose (land and buildings); dividend decision |
| Omni System reverse split (20 Oct 2026) and The Lami price | Delisting-rule compliance |
| Further shareholder-return measures | Dividend reinstatement or further share cancellation |
| Insider ownership filings | Direction of controlling-group trades (filings in Jul–Sep 2026) |
| Group capital allocation | Any new M&A or intra-group transactions (WSI Korea funding) |
Analyst verdict
BioSmart is no longer a card company. It is a thinly capitalized, founder-controlled holding vehicle whose consolidated numbers are driven by a single listed copper-materials subsidiary. The operational story has improved materially:
-
Operating income more than doubled between FY2023 and FY2025.
-
Leverage has halved.
-
1H26 revenue grew 34%, carried by TC Materials' exposure to transformer and EHV-cable demand.
Taken alone, these trends and a share price at about 5x earnings and 0.45x book would suggest a mispriced asset.
The market's skepticism nevertheless has a factual basis. Reported earnings have repeatedly failed to translate into attributable profit or free cash flow. FY2024 attributable net income was essentially zero, and TTM free cash flow is deeply negative after a KRW 33B capex step-up whose purpose is not transparently communicated. The flagship subsidiary missed its listing guidance badly in its first year. Two other listed affiliates are fighting low-price delisting thresholds. Shareholder returns have been negligible since 2022, and there is no investor-relations framework, sell-side coverage or forward guidance to anchor expectations. The persistent holding discount — listed stakes alone exceed the parent's market value — is therefore partly a governance discount that will not close by itself.
Our assessment is that BioSmart offers asymmetric but low-conviction value. The principal swing factor is TC Materials delivering on its capacity ramp with restored margins (5–6% operating margin or better) through 2027. The principal unlock would be an explicit capital-return policy from the controlling shareholder. Absent the second, the first may continue to accrue mainly to TC Materials' minority holders and to further group expansion rather than to BioSmart shareholders.
Classification: deep-value / special-situation. Key confirmation points: 3Q26 margin recovery at TC Materials and any dividend or buyback announcement with the FY2026 results.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / background | Age | 2025 compensation |
|---|---|---|---|---|
Park Hye-rin (박혜린) | Chairman; controlling shareholder (19.91%) | Acquired the predecessor KBC in 2004 and has controlled the group for more than 16 years. Earlier business: tyre imports from 1993. Also inside director/CEO across listed affiliates (Omni System, TC Materials; The Lami from 2026). Non-standing director of WSI Korea. Described by Korean media as an M&A specialist. | Born 1968 (Dealsite) | KRW 850M total (DART 2025; split between salary and bonus not disclosed in retrieved sources) |
Yoon Ho-kwon (윤호권) | CEO / Representative Director; styled Vice-Chairman | Related party holding 3.77%. CEO of Bona Networks. Was a non-standing director at TC Materials before the 2025 move to inside director. Non-standing director at WSI Korea. | — | KRW 830M total (DART 2025) |
Han Kyung-taek | Chief Financial Officer | — | — | Below disclosure threshold |
"Ho-Gwon Yoon" | Chief Operating Officer (per S&P) | — | — | — |
Hyun Byung-taek (현병택) | Group vice-chairman; CEO of bio division / Austin Pharm (appointed Apr 2021) | Former deputy president, IBK Industrial Bank. | — | — |
“—” = not publicly disclosed.
Governance Overview
| Item | Detail |
|---|---|
Registered directors/auditors | 4 (DART 2025 pay disclosure basis) |
Independence, committees, chair/CEO separation | Not publicly disclosed in retrieved sources. Chair (Park) and CEO (Yoon) are separate individuals but closely aligned; both are in the controlling group. |
Group-level governance concerns | Dealsite (Jul 2025) noted that appointing both Park and Yoon as inside directors at TC Materials would push its outside-director ratio below the 25% legal minimum, requiring a board reshuffle. Dealsite (Apr 2026) characterized the group as lacking shareholder-return policies and IR, which it ties to persistent undervaluation. |
Board & Management Changes
| Date | Change |
|---|---|
Apr 2021 | Hyun Byung-taek joins as group vice-chairman |
Jul 2025 | Park Hye-rin returns to the TC Materials board as inside director (EGM agenda); Yoon Ho-kwon moves from non-standing to inside director (Dealsite) |
c. Apr 2026 | Park Hye-rin takes direct leadership of The Lami (Dealsite) |
Major Shareholders
| Holder | Stake % (end-2025) |
|---|---|
Park Hye-rin | 19.91 |
Yoon Ho-kwon | 3.77 |
Witz Energy (위지트에너지) | 1.01 |
Lim Jong-il | 0.03 |
Controlling group total | 24.72 |
Minority shareholders (16,375 holders) | 61.62 |
Insiders (S&P definition) | 25.43 |
Institutions (S&P) | 4.50 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Positioning versus BioSmart | Data |
|---|---|---|---|
Cards | KONA I (KOSDAQ 052400) | Korea's leading smart-card and COS company; vertically integrated (own COS); about 100M cards a year of capacity (2017); global #4 in financial cards (2016) | FY2025 revenue KRW 309.2B (+30.8%); net income KRW 74.6B; market cap KRW 589.8B (Jul 2026); 354 employees |
Cards | UbiVelox (KOSDAQ 089850) | Own-COS card maker; supplies BC Card annually; exports to China | — |
Cards | ICK (IC Korea) | E-money and card maker; about 30% domestic e-money share (2013) | — |
Cards | KONA C / KONA M (KONA I subsidiaries) | Card manufacturing arms; metal and fingerprint cards | Consolidated in KONA I |
Cards (global) | Thales, IDEMIA, CPI Card Group | Global card and personalization majors | Not benchmarked |
Copper winding (CTC/flat wire) | Samdong (삼동) | Cited as the only other supplier of oxygen-free CTC/copper for EHV transformers in Korea alongside TC Materials (Finance Scope, May 2025) | — |
Copper / cable materials | LS Cable & System, Taihan Cable | Customers; vertically integrated cable makers | Not benchmarked |
Pharma (generics) | Korean mid-size generic makers | Austin Pharm is a small player (last disclosed revenue KRW 63.7B, 2021) | Not benchmarked |
Liquor payment | NHN KCP (partner) and other PG / VAN providers | Niche, regulation-created market | Not benchmarked |
AMI / meters (Omni System) | Other Korean AMI vendors | Omni had about 75% digital-meter share in 2006 | Historical |
Peer Comparison FY2025
| Metric | BioSmart | KONA I | TC Materials |
|---|---|---|---|
Revenue, FY2025 (KRW Bn) | 482.8 | 309.2 | 299.1 (standalone) |
Revenue growth FY2025 (%) | -0.3 | 30.8 | — |
Operating margin FY2025 (%) | 4.69 | — | 2.27 |
Net income FY2025 (KRW Bn) | 9.0 | 74.6 | — |
R&D intensity (%) | 0.14 | — | — |
Market cap (KRW Bn) | 67.9 (15 Oct 2026) | 589.8 (28 Jul 2026) | 171.5 (22 Jul 2026) |
Dividend yield (%) | 0 | 4.0 | — |
“—” = not publicly disclosed.



